Phytecs explores innovative clinical and preclinical research into endocannabinoid dysregulation syndrome to expand the options available to physicians, healthcare professionals and patients.
Phytecs educates consumers about the critical importance of endocannabinoid function in health and disease. Phytecs develops products that help individuals maintain propoer endocannabinoid function.
Phytecs provides evidence-based guidance to government agencies around the globe as they develop regulations to supervise research and development of products and therapies targeting the endocannabinoid system.
Phytecs provides its strategic partners with formulations that leverage the most current scientific understanding of endocannabinoid regulation and dysregulation.
Director of Global Research, Chair of Scientific Advisory Board
The endocannabinoid system regulates many key physiological processes, perhaps extending to the biochemistry underlying individual personalities.
Phytecs researches and develops products that support balanced endocannabinoid system function in both health and disease. Technical innovation by Phytecs in natural products chemistry, genomics and bioinformatics may help create the next generation of cannabinoid medicines.
The endocannabinoid system (ECS) is an essential regulator of bodily function in its many facets. There is hardly any physiological process that is not affected by it to some degree. It is surprising then to realize that the ECS was totally unknown prior to one generation ago. The name derives from the fact that the bodies of all higher animals harbor natural chemicals within that resemble in many respects the activity of tetrahydrocannabinol (THC), the phyto- (plant) cannabinoid that is the main psychoactive component of Cannabis sativa, sometimes derisively labeled as marijuana.